MedPath

GeNeuro Australia PTY Ltd

Ownership
Private
Employees
-
Market Cap
-
Website

Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Other: GNbAC1 Placebo
First Posted Date
2018-07-02
Last Posted Date
2020-10-20
Lead Sponsor
GeNeuro Australia PTY Ltd
Target Recruit Count
24
Registration Number
NCT03574428
Locations
🇦🇺

Scientia Clinical Research Ltd, Sydney, New South Wales, Australia

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

Phase 2
Completed
Conditions
Diabetes Mellitus Type 1
Interventions
Drug: Placebo
First Posted Date
2017-06-07
Last Posted Date
2020-10-20
Lead Sponsor
GeNeuro Australia PTY Ltd
Target Recruit Count
64
Registration Number
NCT03179423
Locations
🇦🇺

Macquarie University Hospital, Macquarie University, New South Wales, Australia

🇦🇺

Eastern Health, Box Hill, Victoria, Australia

🇦🇺

Keogh Institute of Medical Research, Nedlands, Western Australia, Australia

and more 10 locations
© Copyright 2025. All Rights Reserved by MedPath